Novavax’s Big FDA Win Sends Shares Soaring

Novavax just got its COVID shot fully approved by the FDA, making it the only non-mRNA option in the US—and investors are loving it. The stock popped over 20%! This is a huge move, especially with vaccine access in the spotlight lately. Meanwhile, solar stocks are taking a hit as lawmakers threaten to cut clean energy tax credits, and China’s not happy about new US chip restrictions. Wild day in the markets! #Novavax #FDAApproval #StockMarket #CovidVaccine #SolarStocks #Health